Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$32.06 - $44.56 $11.2 Million - $15.6 Million
350,000 New
350,000 $11.9 Million
Q1 2024

May 15, 2024

SELL
$35.22 - $51.88 $1.23 Million - $1.82 Million
-35,000 Reduced 30.43%
80,000 $3.36 Million
Q4 2023

Feb 14, 2024

SELL
$22.61 - $40.65 $1.92 Million - $3.46 Million
-85,000 Reduced 42.5%
115,000 $4.56 Million
Q3 2023

Nov 14, 2023

BUY
$25.45 - $37.46 $5.09 Million - $7.49 Million
200,000 New
200,000 $5.5 Million
Q1 2023

May 15, 2023

SELL
$34.78 - $47.43 $3.04 Million - $4.15 Million
-87,500 Reduced 44.44%
109,400 $3.94 Million
Q3 2022

Nov 14, 2022

SELL
$22.7 - $37.57 $18.7 Million - $30.9 Million
-823,600 Reduced 80.71%
196,900 $5.54 Million
Q2 2022

Aug 15, 2022

BUY
$20.5 - $37.33 $10.6 Million - $19.2 Million
515,300 Added 102.0%
1,020,500 $27.5 Million
Q1 2022

May 13, 2022

BUY
$27.64 - $39.32 $27,640 - $39,320
1,000 Added 0.2%
505,200 $17.2 Million
Q4 2021

Feb 11, 2022

BUY
$35.68 - $56.27 $12.3 Million - $19.4 Million
344,200 Added 215.13%
504,200 $19.5 Million
Q3 2021

Nov 12, 2021

BUY
$28.95 - $55.99 $4.63 Million - $8.96 Million
160,000 New
160,000 $8.64 Million
Q1 2021

May 17, 2021

SELL
$16.19 - $29.91 $1.63 Million - $3 Million
-100,400 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$14.99 - $22.75 $1.5 Million - $2.28 Million
100,400 New
100,400 $1.76 Million

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.18B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.